Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
55.13
-2.24 (-3.90%)
Nov 15, 2024, 4:00 PM EST - Market closed
Revolution Medicines Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 15, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 9,274 | 4,720 | 2,115 | 1,855 | 2,628 | - | |
| Market Cap Growth | 150.04% | 123.15% | 14.03% | -29.43% | - | - | |
| Enterprise Value | 7,811 | 3,969 | 1,525 | 1,278 | 2,195 | - | |
| Last Close Price | 55.13 | 28.68 | 23.82 | 25.17 | 39.59 | - | |
| PS Ratio | 10209.19 | 407.57 | 59.78 | 63.11 | 61.14 | - | |
| PB Ratio | 5.90 | 2.58 | 3.09 | 3.08 | 5.54 | - | |
| P/TBV Ratio | 5.07 | 2.69 | 3.46 | 3.51 | 6.58 | - | |
| EV/Sales Ratio | 10527.17 | 342.78 | 43.11 | 43.48 | 51.07 | - | |
| Debt / Equity Ratio | 0.06 | 0.05 | 0.09 | 0.11 | 0.07 | 0.00 | |
| Asset Turnover | 0.00 | 0.01 | 0.05 | 0.05 | 0.11 | 0.26 | |
| Quick Ratio | 13.98 | 12.89 | 10.48 | 9.66 | 9.48 | 3.05 | |
| Current Ratio | 14.24 | 13.06 | 10.65 | 9.77 | 9.63 | 3.11 | |
| Return on Equity (ROE) | -47.18% | -34.75% | -38.63% | -34.74% | -34.49% | -38.25% | |
| Return on Assets (ROA) | -28.56% | -20.08% | -20.83% | -18.00% | -17.56% | -17.30% | |
| Return on Capital (ROIC) | -30.73% | -21.67% | -22.76% | -19.97% | -20.96% | -27.11% | |
| Earnings Yield | -6.11% | -9.25% | -11.76% | -10.09% | -4.12% | - | |
| FCF Yield | -5.94% | -7.59% | -11.12% | -8.29% | -3.92% | - | |
| Buyback Yield / Dilution | -59.41% | -40.34% | -10.74% | -32.68% | -1879.17% | -20.61% | |
| Total Shareholder Return | -59.41% | -40.34% | -10.74% | -32.68% | -1879.17% | -20.61% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.